File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/humu.9054
- Scopus: eid_2-s2.0-0036724934
- PMID: 12204001
- WOS: WOS:000209087900007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Genotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia.
Title | Genotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia. |
---|---|
Authors | |
Issue Date | 2002 |
Citation | Human Mutation, 2002, v. 20 n. 3, p. 232-233 How to Cite? |
Abstract | We screened 160 unrelated Chinese hypertriglyceridemic subjects for sequence alterations in the promoter and the 10 exons of the lipoprotein lipase (LPL) gene. We identified one reported mutation (L252R), one common polymorphism (S447X), and six novel mutations: V181I, C283Y, S298R and S338F (found in single individuals), L252V (in two individuals), and A71T (in three individuals). Screening of family members of the above probands revealed a total of 19 mutation carriers, most of whom, though not all, displayed reduced LPL activity and mass when compared to normolipidemic control subjects. In in vitro expression studies, A71T, V181I, L252R, L252V and C283Y decreased the specific activity of the gene product. Interestingly, S298R had no effect on the catalytic activity while S338F increased it. A71T and C283Y reduced the secretion of the mutant proteins significantly while V181I, S298R and S338F had mild effects only. The total LPL mass of all the mutant constructs was reduced compared to that of the wild type construct, probably due to the instabilities of the mutant mRNA or the mutant protein. The heterogeneity in phenotypic effects of these mutations is a likely consequence of their variable effects on proteoglycan binding, conformation and interactions with other secondary genetic or environmental factors. Copyright 2002 Wiley-Liss, Inc. |
Persistent Identifier | http://hdl.handle.net/10722/148295 |
ISSN | 2023 Impact Factor: 3.3 2023 SCImago Journal Rankings: 1.686 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, LY | en_US |
dc.contributor.author | Lam, CW | en_US |
dc.contributor.author | Mak, YT | en_US |
dc.contributor.author | Tomlinson, B | en_US |
dc.contributor.author | Tsang, MW | en_US |
dc.contributor.author | Baum, L | en_US |
dc.contributor.author | Masarei, JR | en_US |
dc.contributor.author | Pang, CP | en_US |
dc.date.accessioned | 2012-05-29T06:12:03Z | - |
dc.date.available | 2012-05-29T06:12:03Z | - |
dc.date.issued | 2002 | en_US |
dc.identifier.citation | Human Mutation, 2002, v. 20 n. 3, p. 232-233 | en_US |
dc.identifier.issn | 1098-1004 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/148295 | - |
dc.description.abstract | We screened 160 unrelated Chinese hypertriglyceridemic subjects for sequence alterations in the promoter and the 10 exons of the lipoprotein lipase (LPL) gene. We identified one reported mutation (L252R), one common polymorphism (S447X), and six novel mutations: V181I, C283Y, S298R and S338F (found in single individuals), L252V (in two individuals), and A71T (in three individuals). Screening of family members of the above probands revealed a total of 19 mutation carriers, most of whom, though not all, displayed reduced LPL activity and mass when compared to normolipidemic control subjects. In in vitro expression studies, A71T, V181I, L252R, L252V and C283Y decreased the specific activity of the gene product. Interestingly, S298R had no effect on the catalytic activity while S338F increased it. A71T and C283Y reduced the secretion of the mutant proteins significantly while V181I, S298R and S338F had mild effects only. The total LPL mass of all the mutant constructs was reduced compared to that of the wild type construct, probably due to the instabilities of the mutant mRNA or the mutant protein. The heterogeneity in phenotypic effects of these mutations is a likely consequence of their variable effects on proteoglycan binding, conformation and interactions with other secondary genetic or environmental factors. Copyright 2002 Wiley-Liss, Inc. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Human mutation | en_US |
dc.subject.mesh | Catalysis | en_US |
dc.subject.mesh | China | en_US |
dc.subject.mesh | Dna - Chemistry - Genetics | en_US |
dc.subject.mesh | Dna Mutational Analysis | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Genotype | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypertriglyceridemia - Blood - Genetics | en_US |
dc.subject.mesh | Lipids - Blood | en_US |
dc.subject.mesh | Lipoprotein Lipase - Genetics - Metabolism | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mutation | en_US |
dc.subject.mesh | Phenotype | en_US |
dc.title | Genotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia. | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lam, CW:ching-wanlam@pathology.hku.hk | en_US |
dc.identifier.authority | Lam, CW=rp00260 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1002/humu.9054 | - |
dc.identifier.pmid | 12204001 | - |
dc.identifier.scopus | eid_2-s2.0-0036724934 | en_US |
dc.identifier.volume | 20 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.spage | 232 | en_US |
dc.identifier.epage | 233 | en_US |
dc.identifier.isi | WOS:000209087900007 | - |
dc.identifier.issnl | 1059-7794 | - |